0001181431-13-007054.txt : 20130206 0001181431-13-007054.hdr.sgml : 20130206 20130206101700 ACCESSION NUMBER: 0001181431-13-007054 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130204 FILED AS OF DATE: 20130206 DATE AS OF CHANGE: 20130206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YACHMETZ PHILIP K CENTRAL INDEX KEY: 0001250318 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15313 FILM NUMBER: 13576517 MAIL ADDRESS: STREET 1: 501 LAFAYETTE AVE CITY: WYCKOFF STATE: NJ ZIP: 07481 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rrd369011.xml YACHMETZ FORM 4 X0306 4 2013-02-04 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001250318 YACHMETZ PHILIP K SAVIENT PHARMACEUTICALS, INC. 400 CROSSING BLVD. BRIDGEWATER NJ 08807 0 1 0 0 SVP, General Counsel Common Stock $.01 par value per share 2013-02-04 4 S 0 27297 1.01 D 306904 D Common Stock $.01 par value per share 2013-02-04 4 S 0 3203 1.02 D 303701 D These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 1, 2012 and February 27, 2012. /s/ Philip K. Yachmetz 2013-02-06